Abstract
Get full access to this article
View all access options for this article.
References
1.
Caroff
SN
Mann
SC
. Neuroleptic malignant syndrome . Med Clin North Am
1993 ;77 : 185 –202 .
2.
Buckley
PF
Hutchinson
M
. Neuroleptic malignant syndrome . J Neurol Neurosurg Psychiatry
1995 ;58 : 271 –3 .
3.
Albibi
R
McCallum
RW
. Metoclopramide: Pharmacology and clinical application . Ann Intern Med
1983 ;98 : 86 –95 .
4.
Bateman
DN
Rawlins
MD
Simpson
JM
. Extrapyramidal reactions with metoclopramide . Br Med J
1985 ;291 : 930 –2 .
5.
Robinson
MB
Kennett
RP
Harding
AE
Legg
NJ
. Neuroleptic malignant syndrome associated with metoclopramide (letter) . J Neurol Neurosurg Psychiatry
1985 ;40 :1304 .
6.
Samie
RM
. Neuroleptic malignant—like syndrome induced by metoclopramide . Mov Disord
1987 ;2 : 57 –60 .
7.
Patel
P
Bristow
G
. Postoperative neuroleptic malignant syndrome. A case report . Can J Anaesth
1987 ;34 : 515 –8 .
8.
Friedman
LS
Weinrauch
LA
D'Elia
JA
. Metoclopramide-induced neuroleptic malignant syndrome . Arch Intern Med
1987 ;147 : 1495 –7 .
9.
Patterson
JF
. Neuroleptic malignant syndrome associated with metoclopramide . South Med J
1988 ;81 : 674 –5 .
10.
Cassidy
T
Bansai
SK
. Neuroleptic malignant syndrome associated with metoclopramide (letter) . BMJ
1988 ;296 :214 .
11.
Brower
RD
Dreyer
CF
Kent
TA
. Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea . J Child Neurol
1989 ;4 : 230 –2 .
12.
Henderson
A
Longdon
P
. Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene . Aust N Z J Med
1991 ;21 : 742 –3 .
13.
Nagashima
A
Yao
H
Okada
Y
Sadoshima
S
Takada
Y
Fujishima
M
. A case of metoclopramide-induced neuroleptic malignant syndrome with cerebrospinal lactic acidosis . No To Shinkei
1991 ;43 : 387 –92 .
14.
Donnet
A
Harle
JR
Dumont
JC
Cherif
A Alif
. Neuroleptic malignant syndrome induced by metoclopramide . Biomed Pharmacother
1991 ;45 : 461 –2 .
15.
Bakri
YN
Khan
R
Subhi
J
Kawi
Z
. Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy . Gynecol Oncol
1992 ;44 : 189 –90 .
16.
Krahenbuhl
S
Raisin
J
Herren
T
. Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria . Schweiz Med Wochenschr
1993 ;123 : 1359 –62 .
17.
Shaw
A
Matthews
EE
. Postoperative neuroleptic malignant syndrome . Anaesthesia
1995 ;59 : 246 –7 .
18.
Shintani
S
Shiigai
T
Tsuchija
K
Kikuchi
M
. Hyperventilation alternating with apnea in neuroleptic malignant syndrome associated with metoclopramide and cisapride . J Neurol Sci
1995 ;128 : 232 –3 .
19.
Le Couteur
DG
Kay
T
. Delayed neuroleptic malignant syndrome following cessation of prolonged therapy with metoclopramide (letter) . Aust N Z J Med
1995 ;25 :261 .
20.
Fujita
Y
Yasukawa
T
Mihira
M
Sasaki
T
Yokoya
S
. Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome (letter) . Intensive Care Med
1996 ;22 :717 .
21.
Pope
HG
Keck
PE
McElroy
SL
. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital . Am J Psychiatry
1986 ;143 : 1227 –33 .
22.WHO Collaborating Centre for drug statistics methodology , guidelines for ATC classification and DDD assignment 1996 . WHO Collaborating Centre for Drug Statistics Methodology , Oslo, Norway .